Track the Ishita Drugs & Ind stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €221.3m. The latest transaction was reported on 22 July 2026 (Acquisition). Among the most active insiders: Ishita Pharmaceuticals. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Ishita Drugs & Ind is a company listed on the Bombay Stock Exchange, specializing in the manufacturing of pharmaceutical products. It focuses on the development and production of generic drugs and formulations.